Genentech
Company creating and delivering innovative medicines.
Genentech is a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases. Our transformational discoveries include the first targeted antibody for cancer and the first medicine for primary progressive multiple sclerosis.
Genentech became a member of the Roche Group in March of 2009. As part of their merger agreement, Roche and Genentech combined their pharmaceutical operations in the United States. Genentech's South San Francisco campus now serves as the headquarters for Roche pharmaceutical operations in the United States. Genentech Research and Early Development operates as an independent center within Roche.
Visit website: https://www.gene.com/
Details last updated 30-Jan-2020
People at Genentech
Genentech News
Genentech discontinues cell therapy collaboration with Adaptimmune
FierceBiotech - 12-Apr-2024
The company remains focused on its independent cancer drug development
Read more...$30 million venture philanthropy fund to tackle Alzheimer's
Business Insider - 17-Jul-2018
$ 80 million will be directed towards Alzheimer’s research and drug discovery
Read more...